
Cessatech A/S
- Address
- Kanonbaadsvej 2
Sponsor Overview
assignment
1
sponsored trial
science
2
molecules
location_city
3
research centres
public
1
country
person_search
4
investigators
Specializations
Paediatric Pain Management
Cessatech A/S focuses on pain research in children, with attention to moderate and severe acute pain in acute care settings.
- Analgesia
- Paediatric emergency care
- Acute pain relief
The sponsor’s clinical research activity is centred on evaluating treatment options for pediatric participants requiring timely pain control.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Safety, Tolerability, and Analgesic Efficacy of Intranasal Ketamine Hydrochloride and Sufentanil Citrate in Pediatric Patients with Moderate to Severe Pain | Spain | Not Recruiting |
Data & Insights
science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 2 total (0% not shared with other sponsors)
This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.
hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 3 sites collaborated multiple times
This sponsor has worked with 3 sites across their trial portfolio.
Therapeutic Focus
- 1.Anesthesia and Analgesia1 trial100 other sponsors
Partnered Research Centres
3 centreslocation_city
assignment944Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
- Address
- Paseo De La Castellana 261, 28046 Madrid
location_city
assignment327Hospital Sant Joan De Deu Barcelona
- Address
- Passeig De Sant Joan De Deu 2, 08950 Esplugues de Llobregat
location_city
assignment601Universidade De Santiago De Compostela
- Address
- Calle Choupana Da S/n, 15706 Santiago de Compostela
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Cessatech A/S.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

